Literature DB >> 16571800

Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation.

Zhigang Zhang1, David L Evers, Joseph F McCarville, Jean-Christophe Dantonel, Shu-Mei Huong, Eng-Shang Huang.   

Abstract

Levels of the p53 tumor suppressor protein are increased in human cytomegalovirus (HCMV)-infected cells and may be important for HCMV pathogenesis. In normal cells p53 levels are kept low due to an autoregulatory feedback loop where p53 activates the transcription of mdm2 and mdm2 binds and ubiquitinates p53, targeting p53 for proteasomal degradation. Here we report that, in contrast to uninfected cells, mdm2 was undetectable upon treatment of infected fibroblasts with the proteasome inhibitor MG132. Cellular depletion of mdm2 was reproducible in p53-null cells transfected with the HCMV IE2-86 protein, but not with IE172, independently of the endogenous mdm2 promoter. IE2-86 also prevented the emergence of presumably ubiquitinated species of p53. The regions of IE2-86 important for mdm2 depletion were those containing the sequences corresponding to the putative zinc finger and C-terminal acidic motifs. mdm2 and IE2-86 coimmunoprecipitated in transfected and infected cell lysates and in a cell-free system. IE2-86 blocked mdm2's p53-independent transactivation of the cyclin A promoter in transient-transfection experiments. Pulse-chase experiments revealed that IE2-86 but not IE1-72 or several loss-of-function IE2-86 mutants increased the half-life of p53 and reduced the half-life of mdm2. Short interfering RNA-mediated depletion of IE2-86 restored the ability of HCMV-infected cells to accumulate mdm2 in response to proteasome inhibition. Taken together, the data suggest that specific interactions between IE2-86 and mdm2 cause proteasome-independent degradation of mdm2 and that this may be important for the accumulation of p53 in HCMV-infected cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571800      PMCID: PMC1440454          DOI: 10.1128/JVI.80.8.3833-3843.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

Review 2.  The p53-Mdm2 module and the ubiquitin system.

Authors:  Dan Michael; Moshe Oren
Journal:  Semin Cancer Biol       Date:  2003-02       Impact factor: 15.707

3.  Interactions between human cytomegalovirus IE1-72 and cellular p107: functional domains and mechanisms of up-regulation of cyclin E/cdk2 kinase activity.

Authors:  Zhigang Zhang; Shu-Mei Huong; Xin Wang; David Y Huang; Eng-Shang Huang
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins.

Authors:  C L Malone; D H Vesole; M F Stinski
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter.

Authors:  T W Hermiston; C L Malone; M F Stinski
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

Review 6.  Human tumor suppressor p53 and DNA viruses.

Authors:  S Collot-Teixeira; J Bass; F Denis; S Ranger-Rogez
Journal:  Rev Med Virol       Date:  2004 Sep-Oct       Impact factor: 6.989

7.  Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein.

Authors:  Wolfram Brune; Michael Nevels; Thomas Shenk
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  The putative zinc finger of the human cytomegalovirus IE2 86-kilodalton protein is dispensable for DNA binding and autorepression, thereby demarcating a concise core domain in the C terminus of the protein.

Authors:  Jasmin Asmar; Lüder Wiebusch; Matthias Truss; Christian Hagemeier
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Physical and functional interactions between PML and MDM2.

Authors:  Xiaolong Wei; Zhong Kang Yu; Arivudainambi Ramalingam; Steven R Grossman; Jiang H Yu; Donald B Bloch; Carl G Maki
Journal:  J Biol Chem       Date:  2003-05-19       Impact factor: 5.157

10.  Cyclin A repression in quiescent cells is associated with chromatin remodeling of its promoter and requires Brahma/SNF2alpha.

Authors:  Marjorie Coisy; Virginie Roure; Magali Ribot; Alexandre Philips; Christian Muchardt; Jean-Marie Blanchard; Jean-Christophe Dantonel
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

View more
  13 in total

1.  Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.

Authors:  Heng Yang; Zhi Zheng; Lisa Y Zhao; Qiang Li; Daiqing Liao
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

2.  P2Y2 purinergic receptor modulates virus yield, calcium homeostasis, and cell motility in human cytomegalovirus-infected cells.

Authors:  Saisai Chen; Thomas Shenk; Maciej T Nogalski
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-03       Impact factor: 11.205

3.  The autoregulatory and transactivating functions of the human cytomegalovirus IE86 protein use independent mechanisms for promoter binding.

Authors:  Dustin T Petrik; Kimberly P Schmitt; Mark F Stinski
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

4.  Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.

Authors:  John P Savaryn; Justin M Reitsma; Tarin M Bigley; Brian D Halligan; Zhikang Qian; Dong Yu; Scott S Terhune
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

5.  Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING.

Authors:  Matteo Biolatti; Valentina Dell'Oste; Sara Pautasso; Francesca Gugliesi; Jens von Einem; Christian Krapp; Martin Roelsgaard Jakobsen; Cinzia Borgogna; Marisa Gariglio; Marco De Andrea; Santo Landolfo
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  Role of noncovalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth.

Authors:  Eui Tae Kim; Young-Eui Kim; Yong Ho Huh; Jin-Hyun Ahn
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

7.  Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Authors:  Eung-Soo Hwang; Zhigang Zhang; Haobin Cai; David Y Huang; Shu-Mei Huong; Chang-Yong Cha; Eng-Shang Huang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

8.  Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells.

Authors:  Min Hua Luo; Holger Hannemann; Amit S Kulkarni; Philip H Schwartz; John M O'Dowd; Elizabeth A Fortunato
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

9.  Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses.

Authors:  Rebecca L Sanders; Charles L Clark; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2008-05-07       Impact factor: 5.103

10.  Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells.

Authors:  Koon-Chu Yaiw; Abdul-Aleem Mohammad; Chato Taher; Huanhuan Leah Cui; Helena Costa; Ourania N Kostopoulou; Masany Jung; Alice Assinger; Vanessa Wilhelmi; Jiangning Yang; Klas Strååt; Afsar Rahbar; John Pernow; Cecilia Söderberg-Nauclér
Journal:  Microorganisms       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.